Clinical Trial Update: An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation [Phase 3]

View source ↗

Summary

An open-label Phase 3 study assessing the long-term safety of dapoxetine hydrochloride for rapid ejaculation has completed. The trial included participants with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Premature Ejaculation

Drugs mentioned

• Dapoxetine HCl (dapoxetine hydrochloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Ejaculation, Erectile Dysfunction | Phase 3 | Status: COMPLETED